marijuana stocks news

22nd Century Group, Inc. (XXII)

 

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 1   64   16   448  
Cost of Revenue 2 306 369 (178)
Gross Profit (1) (241) 3   270  
Operating Expenses
Research Development 414 349 708 (222)
Selling General and Administrative 5,135 2,104 3,980 (1,163)
Non Recurring
Others 137 130 267 (71)
Total Operating Expenses
Operating Income or Loss (5,687) (2,825) (2,038) (1,187)
Income from Continuing Operations
Total Other Income/Expenses Net 98 102 (215) (3,837)
Earnings Before Interest And Taxes (5,588) (2,723) (1,961) (5,317)
Interest Expense 2 2 5 (2)
Income Before Tax (5,590) (2,724) (1,966) (5,315)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (5,590) (2,724) (1,966) (5,315)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (5,590) (2,724) (1,966) (5,315)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (5,590) (2,724) (1,966) (5,315)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$FFRMF to Manage Cannabis Cultivation Facility

Future Farm Subsidiary to Manage Cannabis Cultivation Facility Future Farm Technologies Inc.…

MCIG Shows us the Future of Vaping

mCig, Inc. Officially Unveils Next Generation Vapolution 3.0 Vaporizer BELLEVUE, Wash., Oct.…

$EDXC Delivers Autospense(TM) to Canada

Endexx Delivers Autospense(TM) to Canada Endexx Signs First International Lease Contract for…

GW Pharmaceuticals plc (GWPH) Oral Solution Now Available by Prescription in the U.S.

EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine –…